The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Predictive biomarkers of endocrine therapy (ET) for stage IV breast cancer (BC).
C. Shimizu
No relevant relationships to disclose
K. Hashimoto
No relevant relationships to disclose
H. Tsuda
No relevant relationships to disclose
T. Kobayashi
No relevant relationships to disclose
S. Saji
No relevant relationships to disclose
T. Shigekawa
No relevant relationships to disclose
A. Osaki
No relevant relationships to disclose
K. Aogi
No relevant relationships to disclose